Hosted on MSN8m
NICE green lights two blood cancer therapies for NHS useBMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback